Search results

The number of startup shutdowns on Carta hit a new high in Q1, with 254 company closures—a 58% increase compared to last year.

Over the past five years, dilution levels have declined at every stage of startup life. This can have compounding effects for the makeup of company cap tables.

Initial data from Q2 2024 shows modest increases in median valuation and round size across much of the U.S. venture ecosystem.

In a tight market for primary venture fundraising, a historically high number of startups are turning to bridge rounds.

Learn how fundraising works for limited liability companies, including the differences between funding for LLCs vs. corporations, and what types of investors are available.

Learn the differences between pre-money and post-money valuations for private companies and how to calculate preferred share price when pitching investors during a priced round.

IPOs are the lifeblood of venture capital, but they've been few and far between in recent years. Investors are watching to see if the success of some recent high-profile listings will provide a much-needed spark.

Health and biotech VC fundraising surged in the aftermath of the COVID-19 pandemic and has stood strong against market headwinds.

After two-plus years of steady declines, the Series C market may be bouncing back.

These days, investors have more leverage than startups in deal negotiations. How are they choosing to use it?

The geographic diversification of VC has been a developing trend in recent years. Q1 2024 showed a possible reversal.